Diwali is the time of the year when our nation’s children are on holiday and festivities are rampant. Sadly this fun time for children is also when firecrackers and fireworks are available in plenty. The word “firecrackers” evokes quite a bit of emotion and is often associated with great joy but one must realize that the chemical smoke and gases released from firecrackers can be regarded as a serious concern for the capacity of eyes for children.

It is shocking to know that mothers and fathers have been using firecrackers for this long despite it being scientifically proven to be a pollutant and one that can heavily damage children’s eyesight.

But now, as a parent, most people see things differently—firecracker smoke, while dazzling, risks young eyes and health. From choosing eco-friendly lights and indoor activities, ensuring a festive, safe celebration for your children’s well-being is important and necessary. Dr. Neeraj Sanduja, MBBS, MS - Ophthalmology, Ophthalmologist, Eye Surgeon shares all about the toxic effects of smoke from the firecrackers kids so lovingly enjoy bursting and how harmful they can be for their eyes.

Hazardous Effects of Firecracker Smoke

The smoke from firecrackers is a blend of toxic chemicals and fine particles, each carrying potential harm for the delicate tissues of the eyes. Here are some key pollutants present in firecracker smoke that pose specific dangers:

Particulate matter: These are the fumes exhaled from burning that are extremely small but can infiltrate deep into the lungs and eyes creating lesions and scars.

Sulfur dioxide & nitrogen oxides: These gasses emit acid rain, it's easy to comprehend how detrimental it is to the human body.

Heavy metals: If consumed through the skin lead arsenic or any other toxic metals emitted through firecrackers will inflict great damage.

Common Eye Conditions Linked to Firecracker Pollution in Children

Exposure to firecracker smoke can cause a range of immediate symptoms in children, as well as chronic eye problems that may not become apparent until much later. Children are at high risk of developing some symptoms upon exposure to firecracker smoke, and these include:

Red eye syndrome: Clinical eye examinations show that the eyes can be red and watery, as well as itchy due to the smoke's chemicals.

Eye pain: Another common complaint in children is a burning and stinging sensation in the eye areas.

Intolerance to light: The burning of firecrackers leads to the emission of smoke that can irritate the eyes and increase their sensitivity.

Corneal damage: Severe inflammation of the outer layer of the eyeball caused by exposure to smoke may be a more damaging injury caused than previously mentioned damages of the inner layer.

Long-Term Effects of Firecracker Smoke on Eye Health

While some eye issues may appear right after exposure, others may develop subtly and manifest over time, resulting in chronic eye conditions. Dr Neeraj exclaims, "Of great concern is the fact that parents may not notice these initial signs and the signs that are causes are others since these are only some of the diseases that are dangerous but children who continuously come into contact with air polluted by firecrackers may consider the following risks:

Cataracts

Glaucoma

Dry eye syndrome

Tips for Protecting Children’s Eyes During Diwali

Parents can observe the following measures to shield their children's eyes from the harmful effects of firecracker smoke:

Avoid exposure: In the first place, the best way to avoid damaging children’s eyes is to prevent any contact with firecracker smoke. Encourage children to remain in the house or in well-ventilated areas during a firework display.

Wear protective eyewear: In the event that children have to go outside during a firework display, they should wear protective eyewear such as goggles or sunglasses.

Rinse eyes thoroughly: In case of exposure of firework smoke to the child’s eyes, the affected eyes should be washed with plenty of clean water.

Seek medical attention: If a child suffers from intense pain in the eyes, redness in the eyes or any changes in vision after exposure to cracker smoke, he/she should be taken to a medical facility as soon as possible.

Parental Guidance During Diwali

1.⁠ ⁠Educate Children on Firecracker Safety

2.⁠ ⁠Monitor Air Quality Index (AQI)

3.⁠ ⁠Plan Indoor Activities During Peak Pollution Hours

4.⁠ ⁠Encourage Healthy Eye Habits (Regular Exams, Hygiene)

Eco-Friendly Alternatives to Firecrackers

1.⁠ ⁠Eco-Friendly Firecrackers

2.⁠ ⁠Laser Light Shows

3.⁠ ⁠Community Events (Parades, Festivals)

4.⁠ ⁠Indoor Games and Activities

5.⁠ ⁠Environmentally Conscious Celebrations

Firecrackers undoubtedly liven up the festivities; however, the use of firecrackers and their impact on the health of children has caused a lot of concern, especially their vision. It has become crucial to protect young developing eyes from fire cracker pollution which is harmful to them, especially in the long run. In this manner, we are able to assist in the preservation of our children’s eyesight and create safe and happy festive occasions for everyone.

Athletes who spend years training their bodies undergo remarkable physiological changes. Athlete's heart is one of them. It becomes stronger, more efficient, and sometimes even larger. This natural adaptation is known as athlete's heart, a condition that is completely normal in most cases but can occasionally resemble serious heart disease.

What Is Athlete’s Heart?

Understanding the difference between a healthy athletic heart and an underlying cardiac disorder is crucial, especially as awareness grows around sudden cardiac deaths in young athletes.

HealthandMe spoke to Dr. Ruchit Shah, Interventional Cardiologist at Saifee Hospital, Mumbai, who said, “If a person exercises too much, normally more than 60 minutes in most days of the week for a prolonged period of time, the body's need for oxygen and for blood to supply the oxygen rises significantly. This can often be seen in the very intense training regimens of competitive athletes. The heart muscle responds to this extra demand by getting "conditioned" and thickening with time.”

Just like skeletal muscles that get bigger and thicker and with training and exercise, the heart muscle can get bigger and thicker too.

Athlete's heart is usually characterised by a “conditioned heart rate”. People with athlete's hearts will now show symptoms or serious warning signs and thereby won't need a specific treatment for the condition.

Also read: Illinois Governor Claims Trump Continues To Suffer From Dementia

Common Signs Of Athlete’s Heart

Signs include:

• Slow resting heart rate (bradycardia)

• Mild enlargement of the heart on imaging

• Changes on an electrocardiogram (ECG)

• High exercise capacity with no symptoms

Athlete’s Heart Is Different From Cardiac Diseases

The expert also says that athlete's heart is different from serious cardiac diseases like cardiomyopathies, especially hypertrophic obstructive cardiomyopathy (HOCM).

He says, “HOCM is a serious disease, with heart muscle thickening also occurring and causing the left ventricular cavity to narrow. The left ventricle's outflow tract can also become obstructed from this excessive thickening. Athletes with HOCM have a risk of sudden cardiac arrest and death, unlike athletes with athlete's heart.”

An athlete‘s heart, by itself, is considered a benign physiological adaptation and does not require medical intervention.

However, it becomes important to investigate further if an athlete experiences:

• Chest pain during exercise

• Unexplained fainting

• Palpitations

• Shortness of breath out of proportion to exertion

• Reduced exercise performance

• A family history of sudden cardiac death or inherited heart disease

Ignoring these warning signs can delay the diagnosis of potentially serious cardiac conditions. Those who have an athlete’s heart must get periodic cardiac evaluation, do a temporary reduction in training if the diagnosis remains uncertain, and monitor when minor abnormalities are present.

Athlete's heart is proof of the body's extraordinary ability to adapt to sustained physical activity. For most athletes, it represents a healthy, efficient cardiovascular system rather than a medical problem. The challenge lies in distinguishing these normal adaptations from potentially dangerous heart conditions that can look remarkably similar.

Adults under 40 with obesity continue to face a higher risk of cardiovascular disease than their peers with a normal Body Mass Index (BMI), according to a new study published in The Lancet.

The international study, led by researchers at Imperial College London, found that differences in blood pressure and unhealthy cholesterol levels between older adults with obesity and those with a normal BMI have narrowed—or even disappeared—in several high-income countries over the past three decades. In contrast, little or no such improvement was seen among younger adults.

Younger Adults Show No Similar Improvement

The findings suggest that adults under 40 with obesity continue to have higher blood pressure and unhealthy cholesterol levels than those with a normal BMI.

Obesity is a key risk factor for heart disease.

Researchers also found that the use of cholesterol-lowering and blood pressure medications remains low in this age group, supporting the idea that medication has played a key role in reducing cardiovascular risk among older adults.

"While good news for older adults with obesity, our results suggest that cardiovascular health risks remain higher for adults under 40 than for their counterparts with a normal BMI,” said author Ysé d'Ailhaud de Brisis, from the School of Public Health at Imperial.

"Early lifestyle interventions, screening, and, when appropriate, medication in this younger group should be considered to prevent long-term cardiovascular complications linked to obesity," de Brisis added.

Older Adults See Reduced Risk

Since the 1990s, blood pressure and unhealthy cholesterol levels have fallen more rapidly among adults aged 40 to 79 with obesity than among those with a normal BMI in most of the seven high-income countries studied, including England and the US.

The greatest improvements were seen among adults aged 60 to 79. In England and the US older adults with obesity—particularly those with severe obesity—had similar or even lower blood pressure and unhealthy cholesterol levels than those with a normal BMI by the end of the study period.

Heart Medications May Explain the Trend

The researchers said the narrowing gap is largely due to increased use of cholesterol-lowering medications, such as statins, and blood pressure medicines among adults over 40 with obesity.

For example, by the early 2020s, around 70% to 72% of older men with severe obesity in England and the US were taking cholesterol-lowering medication, compared with 40% to 48% of older men with a normal BMI.

“This latest analysis suggests that the observed convergence in cholesterol and blood pressure levels between people aged over 40 with obesity and those with a normal BMI is largely due to statins and other widely accessible medications to reduce cardiovascular risk. That is a significant public health success story, and one we should not lose sight of as new weight-loss medications enter the picture,” said author Lakshya Jain, from the School of Public Health at Imperial.

How Was the Study Conducted?

The researchers analyzed blood pressure and cholesterol data from nearly one million participants across 110 health datasets collected between 1990 and 2024.

The study included people with obesity, overweight and normal BMI from seven high-income countries: England, the US, Japan, South Korea, Taiwan, Thailand and Finland.

The authors also acknowledged limitations of the study such as, the findings may not apply to low- and middle-income countries, where access to cholesterol- and blood pressure-lowering medications is lower. Further, the study could also not assess the impact of different medication doses because prescription data were unavailable.

Popular GLP-1 medications such as Ozempic, Wegovy, and Zepbound are well established for improving metabolic health, lowering blood sugar and promoting weight loss. These blockbuster drugs are also known to reduce the risk of conditions such as heart disease and type 2 diabetes.

Now, researchers are exploring whether these medications could also help slow biological aging and potentially increase longevity.

Study Explores Anti-Aging Potential

A recent US National Institutes of Health (NIH)-backed study, published in the journal Nature, found that Ozempic slowed biological aging in people living with HIV and lipohypertrophy, a condition in which fatty deposits develop under the skin.

People with HIV often experience accelerated aging because of the infection, making them an important group for age-related research, said lead author Dr. Michael Corley, associate professor of medicine at the University of California, San Diego's Stein Institute for Research on Aging, according to The New York Times.

Although the trial was preliminary, Dr. Corley said it "provided us an opportunity to say, hey, is there any signal here that warrants all the hype?"

Also read: Dangerous Heat Dome To Grip Eastern US, Canada, Putting Over 220 Million Lives At Risk: How To Stay Safe

Can GLP-1 Drugs Slow Aging?

Experts believe the findings are promising, but stressed that more research is needed.

Dr. Nicolas Musi, director of the Diabetes and Aging Center at Cedars-Sinai, told NYT that because these drugs reduce the risk of diseases associated with aging, they could potentially improve lifespan as well.

"GLP-1 agonists decrease the incidence of diseases that are related to aging and are associated with decreasing life span. One would assume that they're also potentially going to increase life span and be beneficial for longevity," Dr. Musi said.

Researchers also point to the drugs' anti-inflammatory effects. Chronic inflammation is one of the biological processes linked to aging, said Dr. Thomas Blackwell, professor of general internal medicine at the University of Texas Medical Branch in Galveston.

However, scientists caution that there is currently no evidence showing that GLP-1 drugs provide longevity benefits for people who are already metabolically healthy.

Read More: US Medicare Set To Cover GLP-1 Drugs For Weight Loss: All You Should Know About Eligibility, Costs

What Are GLP-1 Drugs?

Drugs such as Ozempic and Wegovy contain semaglutide, a GLP-1 receptor agonist, while Zepbound and Mounjaro contain tirzepatide.

These medications are approved for the treatment of type 2 diabetes, and some are also approved for chronic weight management.

GLP-1 receptor agonists work by binding to GLP-1 receptors in the body. This increases insulin production in response to food, suppresses glucagon—a hormone that raises blood sugar—and helps regulate blood glucose levels.

What Does GLP-1 Do in the Body?

GLP-1 (glucagon-like peptide-1) is a hormone naturally produced by the small intestine after eating. It plays several important roles in regulating blood sugar and appetite by:

• Stimulating insulin release from the pancreas.
• Suppressing glucagon secretion, which helps prevent unnecessary increases in blood sugar.
• Slowing stomach emptying allows glucose to enter the bloodstream more gradually.
• Increasing feelings of fullness (satiety), which helps reduce food intake.